We have shown that skin is a fertile land where we can grow the elements of any organ that is declining," said Dr. Chandan Sen, director of Ohio State's Center for Regenerative Medicine & Cell Based Therapies, who co-led the study with L. James Lee, professor of chemical and biomolecular engineering with Ohio State's College of Engineering in collaboration with Ohio State's Nanoscale Science and Engineering Center. Ohio State University researchers have developed a device which changes the genetic code of cells for treatment inside a patient's body. The non-invasive tissue nanotransfection technology is based on an engineered protein called CRISPR-Cas9. The TNT technology could be used to repair injured or deteriorating tissue, giving it potentially revolutionary medical applications
Ohio State University researchers have developed a device which changes the genetic code of cells for treatment inside a patient's body. The non-invasive tissue nanotransfection technology is based on an engineered protein called CRISPR-Cas9. The TNT technology could be used to repair injured or deteriorating tissue, giving it potentially revolutionary medical applications